AHK-Cu

Overview

AHK-Cu (alanine-histidine-lysine copper complex) is a small copper-binding tripeptide that emerged from the broader investigation of copper peptides initiated by the discovery of GHK-Cu. AHK-Cu was developed and characterized in the late 1990s and early 2000s as part of efforts to identify related tripeptides with differentiated activity profiles, particularly in hair follicle biology.

Whereas GHK-Cu has been studied across a broad range of tissues — including skin, lung, bone, and nervous system — AHK-Cu research has focused predominantly on dermal papilla cells of the hair follicle. In these cells, AHK-Cu has been investigated for its effects on vascular endothelial growth factor (VEGF) production, which is closely linked to the transition from telogen (resting) to anagen (growth) phase of the hair cycle.

AHK-Cu is frequently included in cosmetic scalp serums and hair-focused topical formulations, often in combination with GHK-Cu. It remains a research-grade compound outside of cosmetic topical applications.

Structure / Chemistry

AHK-Cu consists of three amino acids coordinated with a copper(II) ion:

• Sequence: Ala-His-Lys
• Molecular formula (free peptide): C15H27N6O4
• Molecular weight (free peptide): approximately 354 g/mol
• Copper complex: Cu2+ coordinated via the N-terminal amine, histidine imidazole, and peptide backbone nitrogen

The coordination geometry resembles that of GHK-Cu, though replacement of the N-terminal glycine with alanine introduces a methyl group that slightly alters steric and hydrophobic properties. The histidine and lysine residues are preserved, retaining copper-binding character and electrostatic interaction with anionic cell-surface structures.

Mechanism of Action

Research into AHK-Cu points to several interrelated mechanisms, most characterized in dermal papilla and follicular contexts:

• Copper delivery to metalloenzymes such as lysyl oxidase (collagen/elastin crosslinking) and superoxide dismutase (antioxidant defense)
• Stimulation of VEGF expression in dermal papilla cells, supporting perifollicular vascularization
• Modulation of dermal extracellular matrix remodeling, including collagen and glycosaminoglycan turnover
• Anti-inflammatory and antioxidant effects linked to copper-dependent enzyme activation

Unlike GHK-Cu, which has been characterized as a broad gene-expression modulator affecting thousands of genes, AHK-Cu has a narrower documented profile that is most robust in follicular and dermal tissue.

Research Summary

Pharmacokinetics

Most AHK-Cu investigation has used topical formulations in hydrophilic or liposomal vehicles. Skin penetration is limited by the peptide's hydrophilic character and its copper coordination, though vehicle-assisted delivery and microneedling significantly improve uptake.

Systemic absorption from topical use is generally considered minimal. Where AHK-Cu has been evaluated by injection in animal research, its small size and hydrophilicity produce rapid renal clearance with a plasma half-life in the minutes range. Locally, the peptide's copper payload is transferred to matrix proteins and metalloenzymes at the site of application.

Common Discussion Topics

• Synergistic use of AHK-Cu and GHK-Cu in hair serums
• Comparison of topical vs injectable research formats
• Role of copper coordination in follicular VEGF response
• Distinctions between cosmetic and research-grade purity standards
• Evidence gaps in human clinical trials beyond cosmetic endpoints

Related Compounds

• GHK-Cu — more extensively studied copper tripeptide
• Copper Peptides — broader class overview
• Matrixyl — palmitoyl pentapeptide used in dermatology
• Argireline — acetyl hexapeptide used in cosmetic research
• Collagen Peptides — complementary dermal research compounds

Educational information only. AHK-Cu is used in cosmetic formulations and research contexts; this article does not constitute medical advice or a recommendation for self-administration.